252 related articles for article (PubMed ID: 32276479)
1. Kynurenic Acid Levels are Increased in the CSF of Alzheimer's Disease Patients.
González-Sánchez M; Jiménez J; Narváez A; Antequera D; Llamas-Velasco S; Martín AH; Arjona JAM; Munain AL; Bisa AL; Marco MP; Rodríguez-Núñez M; Pérez-Martínez DA; Villarejo-Galende A; Bartolome F; Domínguez E; Carro E
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32276479
[TBL] [Abstract][Full Text] [Related]
2. Kynurenine metabolism in Alzheimer's disease.
Baran H; Jellinger K; Deecke L
J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
Linderholm KR; Skogh E; Olsson SK; Dahl ML; Holtze M; Engberg G; Samuelsson M; Erhardt S
Schizophr Bull; 2012 May; 38(3):426-32. PubMed ID: 20729465
[TBL] [Abstract][Full Text] [Related]
4. Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis.
Iłzecka J; Kocki T; Stelmasiak Z; Turski WA
Acta Neurol Scand; 2003 Jun; 107(6):412-8. PubMed ID: 12757473
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
Front Immunol; 2022; 13():997240. PubMed ID: 36263032
[TBL] [Abstract][Full Text] [Related]
6. Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's disease.
Knapskog AB; Aksnes M; Edwin TH; Ueland PM; Ulvik A; Fang EF; Eldholm RS; Halaas NB; Saltvedt I; Giil LM; Watne LO
Alzheimers Dement; 2023 Dec; 19(12):5573-5582. PubMed ID: 37264981
[TBL] [Abstract][Full Text] [Related]
7. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
Heyes MP; Saito K; Devinsky O; Nadi NS
Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
[TBL] [Abstract][Full Text] [Related]
8. Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes.
Kepplinger B; Baran H; Kainz A; Ferraz-Leite H; Newcombe J; Kalina P
Neurosignals; 2005; 14(3):126-35. PubMed ID: 16088227
[TBL] [Abstract][Full Text] [Related]
9. Systemic and central nervous system metabolic alterations in Alzheimer's disease.
van der Velpen V; Teav T; Gallart-Ayala H; Mehl F; Konz I; Clark C; Oikonomidi A; Peyratout G; Henry H; Delorenzi M; Ivanisevic J; Popp J
Alzheimers Res Ther; 2019 Nov; 11(1):93. PubMed ID: 31779690
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria.
Holmberg D; Franzén-Röhl E; Idro R; Opoka RO; Bangirana P; Sellgren CM; Wickström R; Färnert A; Schwieler L; Engberg G; John CC
Malar J; 2017 Jul; 16(1):303. PubMed ID: 28754152
[TBL] [Abstract][Full Text] [Related]
11. Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids.
Yan J; Kothur K; Innes EA; Han VX; Jones HF; Patel S; Tsang E; Webster R; Gupta S; Troedson C; Menezes MP; Antony J; Ardern-Holmes S; Tantsis E; Mohammad S; Wienholt L; Pires AS; Heng B; Guillemin GJ; Guller A; Gill D; Bandodkar S; Dale RC
EBioMedicine; 2022 Oct; 84():104280. PubMed ID: 36174397
[TBL] [Abstract][Full Text] [Related]
12. Increased Levels of Kynurenic Acid in the Cerebrospinal Fluid in Patients with Hydrocephalus.
Kepplinger B; Baran H; Kronsteiner C; Reuss J
Neurosignals; 2019; 27(1):1-11. PubMed ID: 31059212
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
14. Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls.
Schwarz MJ; Guillemin GJ; Teipel SJ; Buerger K; Hampel H
Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):345-52. PubMed ID: 23192697
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
16. Kynurenine and its metabolites in Alzheimer's disease patients.
Gulaj E; Pawlak K; Bien B; Pawlak D
Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.
Schwieler L; Larsson MK; Skogh E; Kegel ME; Orhan F; Abdelmoaty S; Finn A; Bhat M; Samuelsson M; Lundberg K; Dahl ML; Sellgren C; Schuppe-Koistinen I; Svensson C; Erhardt S; Engberg G
J Psychiatry Neurosci; 2015 Mar; 40(2):126-33. PubMed ID: 25455350
[TBL] [Abstract][Full Text] [Related]
18. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
19. Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.
Sjögren M; Davidsson P; Wallin A; Granérus AK; Grundström E; Askmark H; Vanmechelen E; Blennow K
Dement Geriatr Cogn Disord; 2002; 13(2):112-8. PubMed ID: 11844893
[TBL] [Abstract][Full Text] [Related]
20. Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.
Wennström M; Nielsen HM; Orhan F; Londos E; Minthon L; Erhardt S
Int J Tryptophan Res; 2014; 7():1-7. PubMed ID: 24855376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
